$13.12
-0.84-6.02%
À la fermeture: -
$10.51
-2.61-19.89%
Après les heures de négociation: 7:59 PM EDT
Comments
Loading...
Activité de trading des initiés
Suivez les dernières activités de délit d'initié Intellia Therapeutics. Restez informé des achats, des ventes et de l'impact sur le marché des actions Intellia Therapeutics.
Qu’est-ce que l’activité d’initié ?
L'activité de délit d'initié implique des initiés de l'entreprise, tels que des dirigeants, des administrateurs et des employés, qui s'engagent dans des transactions sur les actions de leur propre entreprise. Les transactions d'achat et de vente des initiés fournissent des informations précieuses sur leur confiance dans les performances futures de l'entreprise.
Que font les Intellia Therapeutics Inc Insiders ?
À Intellia Therapeutics Inc, une activité interne récente a attiré l'attention. Au cours des 30 derniers jours, les initiés ont déclaré avoir vendu un total de 1.90K actions d'une valeur de $33.06K. ne signalez aucun achat au cours des 30 derniers jours.
Achats et ventes récents notables d’initiés
- Le août 22, 2025 WILLIAM CHASE, le - purchased 100K actions pour $10.03 chacune.
- Le octobre 3, 2025 Birgit Schultes, le EVP, CHIEF SCIENTIFIC OFFICER sold 31 actions pour $17.38 chacune.
- Le octobre 3, 2025 Michael Dube, le VP, CHIEF ACCOUNTING OFFICER sold 1.87K actions pour $17.38 chacune.
Statistiques de propriété pour Intellia Therapeutics Inc
Actions en circulation
107.347M
Actions détenues par les initiés
3.484M
Pourcentage d'actions détenu par les initiés
3.25%
Actions détenues par les institutions
68.394M
Pourcentage d'actions détenu par les institutions
63.7%
Oct 03, 2025 | EVP, CHIEF SCIENTIFIC OFFICER | -31.00 | $17.38 | -$538.78 | SELL | -0.03% | 105.18K | Oct 01 | ||
Oct 03, 2025 | VP, CHIEF ACCOUNTING OFFICER | -1.87K | $17.38 | -$32.52K | SELL | -3.27% | 55.27K | Oct 01 | ||
Aug 22, 2025 | — | 100.00K | $10.03 | $1.00M | BUY | 288.24% | 134.69K | Aug 20 | ||
Jul 25, 2025 | EVP, CHIEF FINANCIAL OFFICER | -7.46K | $14.02 | -$104.62K | SELL | -6.57% | 106.06K | Jul 23 | ||
Jul 03, 2025 | EVP, CHIEF TECHNICAL OFFICER | -1.02K | $9.82 | -$10.04K | SELL | -1.06% | 95.37K | Jul 01 | ||
Jul 03, 2025 | VP, CHIEF ACCOUNTING OFFICER | -2.50K | $9.95 | -$24.90K | SELL | -4.20% | 57.14K | Jul 02 | ||
Jul 02, 2025 | — | -3.09K | $9.40 | -$29.07K | SELL | -11.27% | 24.36K | Jun 30 - Jul 01 | ||
May 01, 2025 | — | -265.00 | $8.50 | -$2.25K | SELL | -1.36% | 19.20K | Apr 29 | ||
Mar 04, 2025 | EVP, CHIEF TECHNICAL OFFICER | 31.32K | $8.99 | -$6.10K | GRANT | 48.90% | 95.37K | Mar 01 - Mar 04 | ||
Mar 04, 2025 | EVP, GENERAL COUNSEL | 37.43K | $8.99 | -$23.12K | GRANT | 50.24% | 111.92K | Mar 01 - Mar 04 | ||
Jan 31, 2025 | — | -265.00 | $9.97 | -$2.64K | SELL | -1.34% | 19.47K | Jan 29 | ||
Jan 07, 2025 | VP, CHIEF ACCOUNTING OFFICER | -1.37K | $12.18 | -$16.71K | SELL | -2.92% | 45.64K | Jan 03 | ||
Jan 07, 2025 | EVP, GENERAL COUNSEL | -7.07K | $12.18 | -$86.16K | SELL | -8.67% | 74.50K | Jan 03 | ||
Jan 07, 2025 | EVP, CHIEF MEDICAL OFFICER | -9.56K | $12.18 | -$116.40K | SELL | -9.83% | 87.67K | Jan 03 | ||
Jan 07, 2025 | EVP, CHIEF BUSINESS OFFICER | -6.50K | $12.18 | -$79.19K | SELL | -9.80% | 59.88K | Jan 03 | ||
Jan 07, 2025 | PRESIDENT AND CEO | -26.81K | $12.18 | -$326.51K | SELL | -2.61% | 999.53K | Jan 03 | ||
Jan 07, 2025 | EVP, CHIEF SCIENTIFIC OFFICER | -8.97K | $12.18 | -$109.21K | SELL | -10.38% | 77.39K | Jan 03 | ||
Jan 06, 2025 | EVP, CHIEF TECHNICAL OFFICER | -7.98K | $12.17 | -$97.09K | SELL | -11.08% | 64.05K | Jan 02 - Jan 03 | ||
Oct 04, 2024 | VP, CHIEF ACCOUNTING OFFICER | -2.01K | $19.01 | -$38.25K | SELL | -4.10% | 47.01K | Oct 02 | ||
Jul 03, 2024 | EVP, CHIEF TECHNICAL OFFICER | -405.00 | $22.93 | -$9.29K | SELL | -0.56% | 71.47K | Jul 01 | ||
Jun 20, 2024 | — | -1.50K | $25.00 | -$37.63K | SELL | -7.74% | 17.95K | Jun 17 | ||
Mar 05, 2024 | EVP, GENERAL COUNSEL | 30.10K | $32.99 | -$75.78K | GRANT | 58.47% | 81.57K | Mar 01 - Mar 04 | ||
Mar 05, 2024 | EVP, CHIEF TECHNICAL OFFICER | 30.63K | $32.99 | -$19.96K | GRANT | 74.98% | 71.47K | Mar 01 - Mar 04 | ||
Jan 10, 2024 | EVP, CHIEF SCIENTIFIC OFFICER | -2.27K | $28.87 | -$65.68K | SELL | -4.92% | 43.93K | Jan 08 | ||
Jan 05, 2024 | PRESIDENT AND CEO | -19.22K | $29.46 | -$566.31K | SELL | -2.08% | 904.90K | Jan 03 | ||
Jan 05, 2024 | EVP, CHIEF MEDICAL OFFICER | -5.84K | $29.46 | -$172.13K | SELL | -9.70% | 54.37K | Jan 03 | ||
Jan 05, 2024 | EVP, CHIEF SCIENTIFIC OFFICER | -5.53K | $29.46 | -$162.97K | SELL | -10.69% | 46.20K | Jan 03 | ||
Jan 05, 2024 | EVP, CHIEF FINANCIAL OFFICER | -5.37K | $29.46 | -$158.05K | SELL | -11.68% | 40.59K | Jan 03 | ||
Jan 05, 2024 | EVP, CHIEF BUSINESS OFFICER | -3.88K | $29.46 | -$114.22K | SELL | -9.49% | 36.99K | Jan 03 | ||
Jan 05, 2024 | EVP, GENERAL COUNSEL | -3.81K | $29.46 | -$112.10K | SELL | -6.88% | 51.47K | Jan 03 | ||
Jan 05, 2024 | EVP, CHIEF TECHNICAL OFFICER | -4.61K | $29.50 | -$135.95K | SELL | -10.14% | 40.84K | Jan 03 | ||
Nov 02, 2023 | DIRECTOR | -265.00 | $23.90 | -$6.33K | SELL | -2.16% | 12.00K | Oct 31 | ||
Aug 02, 2023 | DIRECTOR | -265.00 | $42.33 | -$11.22K | SELL | -2.12% | 12.26K | Jul 31 | ||
Jul 10, 2023 | DIRECTOR | -1.87K | $39.30 | -$73.37K | SELL | -12.97% | 12.53K | Jul 06 | ||
Jul 06, 2023 | EVP, CHIEF TECHNICAL OFFICER | -360.00 | $40.51 | -$14.58K | SELL | -0.79% | 45.15K | Jul 03 | ||
Jun 22, 2023 | EVP, CHIEF TECHNICAL OFFICER | 0.00 | $28.63 | -$163.65K | SELL-OPTIONS | 0.00% | 45.15K | Jun 20 | ||
Mar 03, 2023 | EVP, GENERAL COUNSEL | 35.72K | $43.88 | -$47.74K | GRANT | 182.63% | 55.28K | Mar 01 - Mar 02 | ||
Jan 06, 2023 | EVP, CHIEF SCIENTIFIC OFFICER | -4.84K | $37.82 | -$182.98K | SELL | -21.53% | 17.63K | Jan 04 - Jan 05 | ||
Jan 06, 2023 | PRESIDENT AND CEO | -6.67K | $37.21 | -$248.30K | SELL | -0.80% | 825.24K | Jan 04 | ||
Jan 06, 2023 | EVP, CHIEF BUSINESS OFFICER | -1.81K | $37.21 | -$67.42K | SELL | -9.48% | 17.31K | Jan 04 | ||
Jan 06, 2023 | EVP, CHIEF MEDICAL OFFICER | -2.57K | $37.21 | -$95.78K | SELL | -9.11% | 25.69K | Jan 04 | ||
Jan 06, 2023 | EVP, CHIEF FINANCIAL OFFICER | -2.43K | $37.21 | -$90.31K | SELL | -13.61% | 15.40K | Jan 04 | ||
Jan 06, 2023 | EVP, CHIEF TECHNICAL OFFICER | -2.03K | $37.65 | -$76.36K | SELL | -12.29% | 14.47K | Jul 01 - Jan 04 | ||
Jan 06, 2023 | EVP, GENERAL COUNSEL | -1.14K | $37.21 | -$42.34K | SELL | -5.50% | 19.56K | Jan 04 | ||
Mar 04, 2022 | PRESIDENT AND CEO | 46.34K | $112.25 | -$279.85K | SELL-OPTIONS | 5.96% | 824.07K | Jan 01 - Mar 01 | ||
Mar 03, 2022 | EVP, CHIEF SCIENTIFIC OFFICER | 16.17K | $112.25 | -$128.86K | SELL-OPTIONS | 656.44% | 18.63K | Jan 01 - Mar 01 | ||
Mar 03, 2022 | EVP, CHIEF MEDICAL OFFICER | 15.95K | $112.24 | -$117.96K | SELL-OPTIONS | 181.56% | 24.74K | Jan 01 - Mar 01 | ||
Mar 03, 2022 | EVP, CHIEF FINANCIAL OFFICER | 14.77K | $112.24 | -$113.70K | SELL-OPTIONS | ∞ | 14.77K | Jan 01 - Mar 01 | ||
Nov 09, 2021 | EVP, CHIEF MEDICAL OFFICER | 0.00 | $72.67 | -$288.25K | SELL-OPTIONS | 0.00% | 8.71K | Nov 05 | ||
Oct 15, 2021 | EVP, CHIEF MEDICAL OFFICER | 0.00 | $70.53 | -$277.96K | SELL-OPTIONS | 0.00% | 8.71K | Oct 14 | ||
Oct 13, 2021 | DIRECTOR | 0.00 | $69.19 | -$251.80K | SELL-OPTIONS | 0.00% | 2.09K | Oct 11 | ||
Oct 07, 2021 | DIRECTOR | 0.00 | $74.68 | -$1.12M | SELL-OPTIONS | 0.00% | 2.09K | Oct 05 | ||
Sep 23, 2021 | EVP, CHIEF MEDICAL OFFICER | 0.00 | $81.22 | -$329.26K | SELL-OPTIONS | 0.00% | 791.00 | Sep 21 | ||
Sep 09, 2021 | EVP, CHIEF FINANCIAL OFFICER | 0.00 | $97.35 | -$576.41K | SELL-OPTIONS | 0.00% | 0.00 | Sep 07 | ||
Sep 01, 2021 | PRESIDENT AND CEO | 0.00 | $88.95 | -$17.45M | SELL-OPTIONS | 0.00% | 777.72K | Aug 30 - Sep 01 | ||
Sep 01, 2021 | EVP, CHIEF SCIENTIFIC OFFICER | 0.00 | $84.42 | -$13.66M | SELL-OPTIONS | 0.00% | 2.39K | Aug 30 | ||
Sep 01, 2021 | EVP, CHIEF MEDICAL OFFICER | 0.00 | $85.33 | -$349.01K | SELL-OPTIONS | 0.00% | 791.00 | Aug 30 | ||
Sep 01, 2021 | EVP, CHIEF FINANCIAL OFFICER | 0.00 | $89.22 | -$4.21M | SELL-OPTIONS | 0.00% | 0.00 | Aug 30 - Aug 31 | ||
Aug 25, 2021 | PRESIDENT AND CEO | 0.00 | $82.71 | -$3.76M | SELL-OPTIONS | 0.00% | 777.72K | Aug 23 | ||
Aug 20, 2021 | PRESIDENT AND CEO | 0.00 | $82.34 | -$3.13M | SELL-OPTIONS | 0.00% | 777.72K | Aug 19 | ||
Aug 11, 2021 | EVP, CHIEF MEDICAL OFFICER | 0.00 | $88.34 | -$363.43K | SELL-OPTIONS | 0.00% | 791.00 | Aug 09 | ||
Aug 06, 2021 | EVP, CHIEF SCIENTIFIC OFFICER | 0.00 | $75.82 | -$3.25M | SELL-OPTIONS | 0.00% | 2.39K | Aug 04 | ||
Aug 06, 2021 | EVP, CHIEF FINANCIAL OFFICER | 0.00 | $85.16 | -$2.64M | SELL-OPTIONS | 0.00% | 0.00 | Aug 05 | ||
Jun 29, 2021 | DIRECTOR | -553.38K | $132.73 | -$73.45M | SELL | -98.22% | 10.00K | Jun 28 | ||
Jun 15, 2021 | DIRECTOR | -201.72K | $87.04 | -$17.56M | SELL | -26.37% | 563.38K | Jun 11 - Jun 14 | ||
Apr 30, 2021 | DIRECTOR | -4.51K | $85.43 | -$385.55K | SELL | -0.59% | 765.10K | Apr 29 | ||
Apr 28, 2021 | DIRECTOR | -342.96K | $85.96 | -$29.48M | SELL | -30.83% | 769.61K | Apr 26 - Apr 28 | ||
Apr 07, 2021 | DIRECTOR | -800.00 | $84.98 | -$67.98K | SELL | -0.07% | 1.11M | Apr 05 | ||
Apr 06, 2021 | DIRECTOR | 0.00 | $44.29 | -$568.40K | SELL-OPTIONS | 0.00% | 5.41K | Apr 05 | ||
Apr 02, 2021 | PRESIDENT AND CEO | 32.83K | $48.89 | -$2.19M | SELL-OPTIONS | 4.57% | 751.78K | Apr 01 | ||
Apr 02, 2021 | EVP, GENERAL COUNSEL | 46.55K | $47.49 | -$2.95M | SELL-OPTIONS | 12.31% | 424.60K | Apr 01 | ||
Mar 01, 2021 | DIRECTOR | -501.94K | $60.29 | -$30.26M | SELL | -31.07% | 1.11M | Feb 26 | ||
Feb 09, 2021 | EVP, GENERAL COUNSEL | 9.51K | $46.65 | -$477.48K | SELL-OPTIONS | 2.57% | 380.13K | Feb 09 | ||
Feb 09, 2021 | PRESIDENT AND CEO | 45.73K | $40.62 | -$2.73M | SELL-OPTIONS | 6.79% | 718.95K | Feb 05 - Feb 09 | ||
Feb 03, 2021 | PRESIDENT AND CEO | 139.31K | $41.21 | -$7.15M | SELL-OPTIONS | 26.09% | 673.22K | Feb 01 - Feb 03 | ||
Feb 03, 2021 | EVP, GENERAL COUNSEL | 54.34K | $36.84 | -$2.44M | SELL-OPTIONS | 17.18% | 370.62K | Feb 01 | ||
Jan 05, 2021 | PRESIDENT AND CEO | 8.14K | $55.86 | -$348.51K | SELL-OPTIONS | 1.55% | 533.90K | Dec 31 - Jan 05 | ||
Jan 05, 2021 | EVP, CHIEF OPERATING OFFICER | 3.42K | $55.86 | -$76.92K | SELL-OPTIONS | 25.79% | 16.66K | Dec 31 - Jan 05 | ||
Jan 05, 2021 | EVP, GENERAL COUNSEL | 2.71K | $55.86 | -$116.08K | SELL-OPTIONS | 0.87% | 314.20K | Dec 31 - Jan 05 | ||
Dec 18, 2020 | — | 0.00 | $36.00 | -$3.12M | OPTION EXERCISE | 0.00% | 5.00K | Dec 17 | ||
Dec 03, 2020 | — | 1.64K | $26.04 | -$59.13K | OPTION EXERCISE | 0.53% | 310.92K | Dec 01 | ||
Nov 27, 2020 | — | 0.00 | $27.37 | -$783.90K | OPTION EXERCISE | 0.00% | 525.77K | Nov 27 | ||
Nov 25, 2020 | — | 0.00 | $21.41 | -$1.46M | OPTION EXERCISE | 0.00% | 525.77K | Nov 25 | ||
Nov 18, 2020 | — | 0.00 | $24.29 | -$388.40K | OPTION EXERCISE | 0.00% | 525.77K | Nov 16 | ||
Nov 18, 2020 | — | 4.76K | $21.30 | -$134.47K | OPTION EXERCISE | 1.56% | 309.28K | Nov 16 - Nov 18 | ||
Nov 06, 2020 | — | 1.64K | $20.94 | -$24.79K | OPTION EXERCISE | 0.54% | 304.52K | Nov 04 | ||
Nov 06, 2020 | — | 0.00 | $16.41 | -$958.50K | OPTION EXERCISE | 0.00% | 525.77K | Nov 04 |
FAQ
Est-ce que le trading d'initiés est légal ?
Le trading d'initiés est légal tant que les initiés signalent ces transactions à la SEC. Le trading de titres illégal se produit lorsque l'initié enfreint un devoir fiduciaire ou omet de signaler ses transactions.
Quels sont quelques exemples de manipulation de marché ?
Le trading d'initiés, les schémas de gonflement et de vidage, le front running et les opérations de lavage sont tous des exemples de manipulation de marché. Les investisseurs qui suivent les mouvements d'actifs des initiés devraient réfléchir attentivement à la raison pour laquelle ces initiés échangent leurs actions avant de passer à l'action.
Parcourir transactions d'initiés sur toutes les actions.